Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shanghai Pharmaceutical Expands North; NDRC Price Cuts Impact M&A Targets

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - To accelerate its expansion and strengthen its presence in North China, Shanghai Pharmaceutical Holding Co. in January opened a new representative office in Beijing and established Beijing Shanghai Pharma Aixin Weiye Pharmaceutical Co., to be known as Weiye Pharma, while at the same time announcing the planned acquisition of China Health System

You may also be interested in...



China NT Pharma's Hong Kong IPO Could Trigger Consolidation In Distribution Sector

HONG KONG - China's largest vaccine promotion and sales services provider is expected to go public on the Hong Kong Stock Exchange April 20, which will likely lead to consolidation in China's distribution sector

China NT Pharma's Hong Kong IPO Could Trigger Consolidation In Distribution Sector

HONG KONG - China's largest vaccine promotion and sales services provider is expected to go public on the Hong Kong Stock Exchange April 20, which will likely lead to consolidation in China's distribution sector

China's NDRC Releases First Set Of Price Cuts; MNCs See Deepest Cuts As Expected

SHANGHAI - China's National Development and Reform Commission has released long-awaited price cuts that will mostly affect multinational pharma companies

UsernamePublicRestriction

Register

LL1133145

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel